Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Non-hodgkins”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)UnknownNCT00007839
What this trial is testing

Beta Alethine in Treating Patients With Low-Grade Lymphoma

Who this might be right for
Lymphoma
LifeTime Pharmaceuticals
Early research (Phase 1)Study completedNCT00049712
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Looking for participantsNCT06343311
What this trial is testing

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
B-Cell Non-Hodgkin's Lymphoma (NHL)Lymphoma, Non-HodgkinsLymphomas Non-Hodgkin's B-Cell+12 more
Estrella Biopharma, Inc. 21
Early research (Phase 1)Study completedNCT00718757
What this trial is testing

Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies

Who this might be right for
Non-Hodgkins LymphomaHodgkin's DiseaseAcute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 4
Large-scale testing (Phase 3)Study completedNCT00088530
What this trial is testing

BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Lymphoma, Non-Hodgkin
CTI BioPharma 140
Testing effectiveness (Phase 2)Study completedNCT00005824
What this trial is testing

Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00193479
What this trial is testing

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC 51
Testing effectiveness (Phase 2)Study completedNCT00317785
What this trial is testing

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 50
Early research (Phase 1)Study completedNCT00536835
What this trial is testing

Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 41
Early research (Phase 1)Ended earlyNCT01678443
What this trial is testing

Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+30 more
Fred Hutchinson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00550615
What this trial is testing

Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
University of Nebraska 38
Testing effectiveness (Phase 2)Ended earlyNCT00691652
What this trial is testing

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 2
Early research (Phase 1)Study completedNCT01290549
What this trial is testing

Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma

Who this might be right for
Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Genentech, Inc. 95
Testing effectiveness (Phase 2)Study completedNCT00049439
What this trial is testing

Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00003572
What this trial is testing

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Next Page